. . . . . . . . . . . . . . . . . . "TextLocation" . "Results" . "a(SCHEM:SP600125) -| (gtp(p(HGNC:HRAS)) -> path(MESHD:Neoplasms))" . "gtp(p(HGNC:HRAS)) -> path(MESHD:Neoplasms)" . "Approximately 2000 hand curated statements drawn from 57 PubMeds." . "Copyright (c) 2011-2012, Selventa. All Rights Reserved." . "BEL Framework Small Corpus Document" . "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License" . . "20131211" . "Ras-driven epidermal neoplasias generated on the surface of immunodeficient SCID mice\nwere treated topically with DMSO vehicle or SP600125 daily for 5 weeks. DMSO\nand untreated control tissues displayed typical findings of neoplasia, including\ninvasion and disruption of the BMZ, as visualized by type VII collagen staining\n(Fig. 2A). In contrast, tissues treated with SP600125 lacked invasive neoplasia\nand retained sharp delineation of the BMZ, with a humanspecific desmoglein-3\nantibody confirming the human origin of these tissues (Fig. 2A)." . . "support@belframework.org" . "Selventa" . . . . "2014-07-03T14:31:17.270+02:00"^^ . . .